{"id":41981,"date":"2025-09-22T15:27:21","date_gmt":"2025-09-22T07:27:21","guid":{"rendered":"https:\/\/flcube.com\/?p=41981"},"modified":"2025-09-22T15:27:22","modified_gmt":"2025-09-22T07:27:22","slug":"nhsa-completes-2025-drug-negotiation-review-car%e2%80%91t-therapies-clear-the-hurdle","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=41981","title":{"rendered":"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle"},"content":{"rendered":"\n<p>The <strong>National Healthcare Security Administration<\/strong> (NHSA) announced today that the expert review for the 2025 drug negotiations has been finalized. Companies that have confirmed participation in the negotiations, bidding, and price discussions are urged to submit the required documentation to the National Healthcare Service Platform by <strong>5\u202fp.m. on September\u202f30<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-review-outcomes\">Review Outcomes<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Selective Pass Rate<\/strong> \u2013 Internal estimates suggest that fewer than half of the total applications advanced past the expert review, underscoring the stringent pricing and value criteria applied by the NHSA.<\/li>\n\n\n\n<li><strong>CAR\u2011T Breakthrough<\/strong> \u2013 All <strong>five CAR\u2011T<\/strong> products\u2014previously excluded from the national reimbursement list due to their steep cost (\u2248\u202f1\u202fmillion yuan per dose)\u2014successfully cleared the review. This marks a significant shift in the agency\u2019s stance toward high\u2011price, high\u2011impact therapies.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-implications-for-stakeholders\">Implications for Stakeholders<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pricing Dynamics<\/strong> \u2013 The inclusion of CAR\u2011T therapies may prompt a recalibration of price negotiation strategies for other advanced biologics.<\/li>\n\n\n\n<li><strong>Market Access<\/strong> \u2013 Companies that meet the documentation deadline will gain expedited access to the national reimbursement system, potentially unlocking substantial commercial opportunities.<\/li>\n\n\n\n<li><strong>Regulatory Focus<\/strong> \u2013 The high stringency of the review highlights the NHSA\u2019s continued emphasis on cost\u2011effectiveness and evidence\u2011based value assessments.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The National Healthcare Security Administration (NHSA) announced today that the expert review for the 2025&#8230;<\/p>\n","protected":false},"author":1,"featured_media":41985,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[67,75,74],"class_list":["post-41981","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-policy-regulatory","tag-nhsa-prev-smia","tag-price-negotiations","tag-rdl"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The National Healthcare Security Administration (NHSA) announced today that the expert review for the 2025 drug negotiations has been finalized. Companies that have confirmed participation in the negotiations, bidding, and price discussions are urged to submit the required documentation to the National Healthcare Service Platform by 5\u202fp.m. on September\u202f30.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=41981\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle\" \/>\n<meta property=\"og:description\" content=\"The National Healthcare Security Administration (NHSA) announced today that the expert review for the 2025 drug negotiations has been finalized. Companies that have confirmed participation in the negotiations, bidding, and price discussions are urged to submit the required documentation to the National Healthcare Service Platform by 5\u202fp.m. on September\u202f30.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=41981\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-22T07:27:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-22T07:27:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2207.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41981#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41981\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle\",\"datePublished\":\"2025-09-22T07:27:21+00:00\",\"dateModified\":\"2025-09-22T07:27:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41981\"},\"wordCount\":207,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41981#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2207.webp\",\"keywords\":[\"NHSA (prev. SMIA)\",\"Price negotiations\",\"RDL\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41981#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41981\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=41981\",\"name\":\"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41981#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41981#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2207.webp\",\"datePublished\":\"2025-09-22T07:27:21+00:00\",\"dateModified\":\"2025-09-22T07:27:22+00:00\",\"description\":\"The National Healthcare Security Administration (NHSA) announced today that the expert review for the 2025 drug negotiations has been finalized. Companies that have confirmed participation in the negotiations, bidding, and price discussions are urged to submit the required documentation to the National Healthcare Service Platform by 5\u202fp.m. on September\u202f30.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41981#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41981\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41981#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2207.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/2207.webp\",\"width\":1080,\"height\":608,\"caption\":\"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41981#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle - Insight, China&#039;s Pharmaceutical Industry","description":"The National Healthcare Security Administration (NHSA) announced today that the expert review for the 2025 drug negotiations has been finalized. Companies that have confirmed participation in the negotiations, bidding, and price discussions are urged to submit the required documentation to the National Healthcare Service Platform by 5\u202fp.m. on September\u202f30.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=41981","og_locale":"en_US","og_type":"article","og_title":"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle","og_description":"The National Healthcare Security Administration (NHSA) announced today that the expert review for the 2025 drug negotiations has been finalized. Companies that have confirmed participation in the negotiations, bidding, and price discussions are urged to submit the required documentation to the National Healthcare Service Platform by 5\u202fp.m. on September\u202f30.","og_url":"https:\/\/flcube.com\/?p=41981","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-22T07:27:21+00:00","article_modified_time":"2025-09-22T07:27:22+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2207.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=41981#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=41981"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle","datePublished":"2025-09-22T07:27:21+00:00","dateModified":"2025-09-22T07:27:22+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=41981"},"wordCount":207,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=41981#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2207.webp","keywords":["NHSA (prev. SMIA)","Price negotiations","RDL"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=41981#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=41981","url":"https:\/\/flcube.com\/?p=41981","name":"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=41981#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=41981#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2207.webp","datePublished":"2025-09-22T07:27:21+00:00","dateModified":"2025-09-22T07:27:22+00:00","description":"The National Healthcare Security Administration (NHSA) announced today that the expert review for the 2025 drug negotiations has been finalized. Companies that have confirmed participation in the negotiations, bidding, and price discussions are urged to submit the required documentation to the National Healthcare Service Platform by 5\u202fp.m. on September\u202f30.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=41981#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=41981"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=41981#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2207.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2207.webp","width":1080,"height":608,"caption":"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=41981#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"NHSA Completes 2025 Drug Negotiation Review; CAR\u2011T Therapies Clear the Hurdle"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/2207.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41981","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41981"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41981\/revisions"}],"predecessor-version":[{"id":41987,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41981\/revisions\/41987"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/41985"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41981"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41981"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41981"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}